Aarti Pharmalabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Aarti Pharmalabs Ltd · Outcome · 29 Oct 2026, 2:25 am
Aarti Pharmalabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 61,045 (+45.9% YoY | +13.9% QoQ) ■ EBITDA: 13,516 (+110.0% YoY | -0.7% QoQ) ■ EBITDA Margin (%): 22.1 (+676 bps YoY | -326 bps QoQ) ■ PAT: 7,147 (+248.8% YoY | -6.1% QoQ) ■ EPS (INR): 7.87 (+248.2% YoY | -6.2% QoQ)
Original exchange filing (PDF)
More announcements from Aarti Pharmalabs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company · 16 Nov 2026
- Q2 FY 27 Earnings Call Transcript · 04 Nov 2026
- Audio Recording of Conference Call for Investor and Analysts · 30 Oct 2026
- Q2 FY 2027 Investor Presentation · 29 Oct 2026
- Please find enclosed · 29 Oct 2026
- Please find enclosed · 29 Oct 2026
- Please find enclosed · 29 Oct 2026
- Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 29 Oct 2026
